Migraine Trial, Recruiting NCT07671703 Sponsor: Hochschule Osnabruck Condition: Migraine
Back to Migraine

Migraine Trial, Recruiting

NCT07671703
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 18 and 70 years old.
  • People who have been diagnosed with migraine by a headache specialist, using a recognised international standard for diagnosing headache disorders (ICHD-3).
  • People who have had migraine symptoms for more than 3 months, with headaches happening on at least 2 days per month.
  • People who are willing to sign a consent form before taking part in the trial.
  • People who complete a specific self-assessment questionnaire about their migraine symptoms, used to confirm the diagnosis and determine whether the migraine is episodic or chronic.

Who may not be able to join:

  • People who have other types of headache disorders, separate from migraine.
  • People who have an active neurological condition or show abnormal results on a neurological examination.
  • People who have rheumatic diseases, vascular (blood vessel) diseases, cancer, or other serious health conditions.
  • People who have a long-term pain condition alongside their migraine, such as fibromyalgia.
  • People who have a diagnosed mental health condition, such as major depression or schizophrenia.
  • People with a history of substance abuse.
  • People who have received physiotherapy for headaches or neck pain in the 3 months before joining the trial.
  • People who have had surgery involving the jaw, neck (cervical spine), or head at any point.
  • People who are pregnant.
  • People whose pain cannot be clearly linked to migraine.
  • People who are unable or unwilling to sign a consent form.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +49 170 3079512

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hochschule Osnabruck
Registry
ClinicalTrials.gov
Start date
11 February 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

HIT-6™

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov